510(K) Summary
Nov 1 6 2001 kK O(A740
ee

Submitter: Cynosure, Inc.

10 Elizabeth Drive
Chelmsford, MA 01824

Contact: George Cho
Senior Vice President of Medical Technology

Date Summary Prepared: August 16, 2001

Device Trade Name: PhotoGenica ER Laser

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.48

Equivalent Device: Continuum Biomedical CB Erbium / 2.94™ Er:YAG Laser

Device Description: The PhotoGenica ER Laser consists of threé interconnected sections:
the power supply, the water cooling system and the optical bench. At
20 pulses per second and a pulse energy of 2 Joules, the average power
from the laser is 20 watts.

Intended Use: Skin resurfacing in the treatment of wrinkles.

Comparison: The PhotoGenica ER Laser is substantially equivalent to the
Continuum Biomedical CB Erbium / 2.94™ Er:Y AG Laser in terms of
treatment wavelength, pulse duration, pulse energy, and biological
effects.

Nonclinical Performance Data: none

Clinical Performance Data: none ;

Conclusion: The PhotoGenica ER Laser is another safe and effective way to
remove or reduce wrinkles, and to ablate or excise tissue.

Additional Information: None requested at this time

ey
f & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
s I
hanes Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Mr. George Cho
Senior Vice President NOV 1 6 2001
of Medical Technology
Cynosure, Inc.
10 Elizabeth Drive
Chelmsford, Massachusetts 01824
Re: K012790
Trade/Device Name: PhotoGenica ER Laser
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology.
Regulatory Class: II
Product Code: GEX
Dated: August 16, 2001
Received: August 20, 2001
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional! controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sea oben { i]
: Celia M. Witten, Ph.D., M.D.
f Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

P. :
Nov 1 6 2001 see of
510(k) Number (if known): KO 2%) 4 0
Device Name: _ Cynosure PhotoGenica ER Laser
Indications For Use:
The PhotoGenica ER laser is used for skin resurfacing in the treatment of wrinkles and for the
incision, excision ablation or vaporization of soft bodily tissues.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) .
Division of General, Restorative
and Neurological Devices
/ 510(%) Number 422 (2
Prescription Use OR Over-The-Counter Use.
(Optional Format 1-2-96)

